The Asia Pacific Carrier Screening Market was valued at $188.1 Million in 2023 and projected to reach to $357.4 Million by 2028, representing a compound annual growth rate of 13.7%. The Asia Pacific carrier screening market is positioned for sustained growth through 2028, driven by demographic shifts, increasing healthcare awareness, and rising disposable incomes across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific carrier screening market is growing at 13.7% CAGR, expanding from $188.1 million in 2023 to $357.4 million by 2028, demonstrating strong regional demand for genetic diagnostic solutions.
Rising awareness of genetic disorders and hereditary conditions across Asia Pacific populations is driving adoption of carrier screening programs among healthcare providers and expectant parents.
Expanding healthcare expenditure across Asia Pacific nations, coupled with government initiatives supporting preventive medicine, is accelerating infrastructure development for advanced diagnostic technologies.
Improved access to advanced diagnostic and sequencing technologies in Asia Pacific is enabling broader implementation of carrier screening programs in both developed and emerging markets.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | PULMONARY CONDITIONS (Medical Condition) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 19.7% from 2023 to 2028 |
| Largest Segment | SERVICES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 2.2 (2023) |
| Revenue Forecast (Billions) | ~USD 5.4 (2028) |
| Segments Covered | Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028 |
6 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|
The Asia Pacific carrier screening market was valued at $188.1 million in 2023 and is projected to reach $357.4 million by 2028.
Asia Pacific's carrier screening market is expected to grow at a compound annual growth rate (CAGR) of 13.7% from 2023 to 2028.
Developed economies in Asia Pacific such as Australia, Japan, and Singapore are leading market growth due to advanced healthcare infrastructure and higher adoption rates of genetic screening services.
Key drivers in Asia Pacific include rising healthcare expenditure, increased awareness of genetic disorders, delayed childbearing trends, and expanding access to advanced diagnostic technologies.
Asia Pacific offers significant opportunities through regulatory framework development, infrastructure investment in emerging markets, and targeted outreach to underserved populations with high prevalence of inherited genetic conditions.
The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.
Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Carrier Screening Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report